You're reading the free version. Trader adds the live tape and alerts.
Start tracking
EWTX Sale Disclosure
Russell Alan J · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$2.74M
Russell Alan J Chief Scientific Officer
EWTX
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
EWTX daily price context
Close on/before transaction
$39.15
Jul 1, 2026
First close after public filing
$40.1
Jul 6, 2026
30-day return after filing
-4.29%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 69,648 shares @ $39.41
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001853529-26-000001
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$7.95M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Edgewise Therapeutics, Inc. EWTX | Exercise | Jul 1, 2026 | $58.66K |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Jul 1, 2026 | $12.54K |
| Edgewise Therapeutics, Inc. EWTX | Sale | Jul 1, 2026 | $5.14M |
| Edgewise Therapeutics, Inc. EWTX Current | Sale | Jul 1, 2026 | $2.74M |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Jul 1, 2026 | $0 |
| Edgewise Therapeutics, Inc. EWTX | Exercise | Jul 1, 2026 | $0 |